Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022

BACKGROUND: Sero-surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can reveal trends and differences in subgroups and capture undetected or unreported infections that are not included in case-based surveillance systems. METHODS: Cross-sectional, convenience samples of remn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegand, Ryan E., Deng, Yangyang, Deng, Xiaoyi, Lee, Adam, Meyer, William A., Letovsky, Stanley, Charles, Myrna D., Gundlapalli, Adi V., MacNeil, Adam, Hall, Aron J., Thornburg, Natalie J., Jones, Jefferson, Iachan, Ronaldo, Clarke, Kristie E.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716971/
https://www.ncbi.nlm.nih.gov/pubmed/36479424
http://dx.doi.org/10.1016/j.lana.2022.100403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716971/
https://www.ncbi.nlm.nih.gov/pubmed/36479424
http://dx.doi.org/10.1016/j.lana.2022.100403

Ejemplares similares